•  
  •  
  •  
  •  

2026-02-22 21:56:38

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • IDFC FIRST Bank Flags ₹590 Cr Fraud in Chandigarh Branch
  • Shri Balaji Valve Components Ltd receives bulk export order from Saudi Arabia
  • Hilltone Software Expands Gases Vertical with CO₂ and Argon
  • Sharika Enterprises Ltd receives order worth Rs. 64.47 lakhs
  • Prestige Group signs definitive agreement with BMRCL to adopt Bellandur Metro Station

Keywords Selected:  GenericVersion

Stock Report

  • Lupin Launches Authorized Generic Version of Ravicti® in the United States
  • NATCO launches Bosentan Tablets for Oral Suspension in the United States with 180-day exclusivity
  • Lupin Launches First Generic of Pred Forte in the United States
  • Natco Pharma Ltd announces submission of Abbreviated New Drug Application
  • Glenmark Pharmaceuticals launches Bumetanide Injection
  • Lupin announces UK MHRA Approval of Lutio® for Treatment of COPD
  • Unichem Laboratories receives ANDA approval for Labetalol Hydrochloride Tablets
  • Glenmark Pharmaceuticals receives ANDA approval for generic version of Taytulla®
  • Dr. Reddy's Laboratories announces launch of the generic version of Nexavar in the U.S. market
  • NATCO announces Launch of First Generic Version of Nexavar® (Sorafenib) Tablets in the U.S. Market
  • Indoco Remedies receives USFDA approval for Lacosamide Tablets
  • NATCO Launches First Generic Version of Revlimid® in the U.S. market
  • Dr. Reddy's Laboratories launches its authorized generic version of VASOSTRICT® Vials in the U.S. Market
  • Lupin Launches Authorized Generic Version of Antara® in the United States

Latest Post

  • IDFC FIRST Bank Flags ₹590 Cr Fraud in Chandigarh Branch
  • Shri Balaji Valve Components Ltd receives bulk export order from Saudi Arabia
  • Hilltone Software Expands Gases Vertical with CO₂ and Argon
  • Sharika Enterprises Ltd receives order worth Rs. 64.47 lakhs
  • Prestige Group signs definitive agreement with BMRCL to adopt Bellandur Metro Station


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2025